Assessment of Radiation Doses Delivered to Organs at Risk Among Patients With Early-Stage Favorable Hodgkin Lymphoma Treated With Contemporary Radiation Therapy-Reference-Cited by-同舟云学术

Assessment of Radiation Doses Delivered to Organs at Risk Among Patients With Early-Stage Favorable Hodgkin Lymphoma Treated With Contemporary Radiation Therapy

Published:2020-09-29 Issue:9 Volume:3 Page:e2013935
ISSN:2574-3805
Container-title:JAMA Network Open
language:en
Short-container-title:JAMA Netw Open

Author:

Pinnix Chelsea C.¹,Gunther Jillian R.¹,Fang Penny¹,Bankston Mikaela E¹,Milgrom Sarah A.²,Boyce David¹,Lee Hun Ju³,Nair Ranjit³,Steiner Raphael³,Strati Paolo³,Ahmed Sairah³,Iyer Swaminathan P.³,Westin Jason³,Parmar Simrit³,Rodriguez M. Alma³,Nastoupil Loretta³,Neelapu Sattva³,Flowers Christopher³,Dabaja Bouthaina S.¹

Affiliation:

1. Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston

2. Department of Radiation Oncology, University of Colorado, Denver

3. Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2770978/pinnix_2020_oi_200527_1600357368.24575.pdf

Reference34 articles.

1. ABVD alone versus radiation-based therapy in limited-stage Hodgkin’s lymphoma.;Meyer;N Engl J Med,2012